EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 84 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $8,892,000 | -2.3% | 1,092,394 | +15.2% | 1.12% | -49.4% |
Q2 2020 | $9,099,000 | +95.7% | 947,852 | +38.6% | 2.22% | +246.5% |
Q1 2020 | $4,650,000 | -63.2% | 683,828 | -19.3% | 0.64% | -65.3% |
Q4 2019 | $12,625,000 | +45.4% | 847,284 | 0.0% | 1.85% | +75.7% |
Q3 2019 | $8,685,000 | -3.3% | 847,284 | 0.0% | 1.05% | +3.6% |
Q2 2019 | $8,981,000 | +17.4% | 847,284 | +54.8% | 1.02% | -0.8% |
Q1 2019 | $7,651,000 | +37.6% | 547,284 | 0.0% | 1.02% | +38.1% |
Q4 2018 | $5,560,000 | – | 547,284 | – | 0.74% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |